Abstract Retinal inflammation is a key determinant of visual prognosis in uveitis, yet its assessment on fluorescein angiography remains subjective, labor-intensive, and insufficiently scalable for clinical trials or large cohort studies. Fluorescein angiography is the gold standard for assessing retinal inflammation. However, its scoring remains challenging, as the process is complex and time-consuming, limiting routine use in clinical trials and patient care.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Muriel
Contact Muriel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack